Assessing Bruker (BRKR) Valuation After New Scientific Instrument Launches At Analytica 2026

Simply Wall St.

03/26

AdvertisementConference product launches draw fresh attention to Bruker stock Bruker (BRKR) gained 4% after unveiling the iNTApharma system, an expanded Fourier 80 Automation Suite, and the TITAN ...

网页链接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2622383124"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622383124\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622383124?lang=zh_TW&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","is_english":true,"pubTime":"2026-03-26 13:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622383124","market":"sg","top_or_hot":-1,"title":"Assessing Bruker (BRKR) Valuation After New Scientific Instrument Launches At Analytica 2026","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementConference product launches draw fresh attention to Bruker stock Bruker (BRKR) gained 4% after unveiling the iNTApharma system, an expanded Fourier 80 Automation Suite, and the TITAN ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/assessing-bruker-brkr-valuation-after-new-scientific-instrum\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Bruker (BRKR) Valuation After New Scientific Instrument Launches At Analytica 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Bruker (BRKR) Valuation After New Scientific Instrument Launches At Analytica 2026\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Simply Wall St.</strong><span class=\"h-time small\">2026-03-26 13:10</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>AdvertisementConference product launches draw fresh attention to Bruker stock Bruker (BRKR) gained 4% after unveiling the iNTApharma system, an expanded Fourier 80 Automation Suite, and the TITAN ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/assessing-bruker-brkr-valuation-after-new-scientific-instrum\">网页链接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/assessing-bruker-brkr-valuation-after-new-scientific-instrum\">Simply Wall St.</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1815336091.USD","symbol_name":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/assessing-bruker-brkr-valuation-after-new-scientific-instrum","article_id":"2622383124","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/assessing-bruker-brkr-valuation-after-new-scientific-instrum","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622383124","pubTimestamp":1774501816,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Conference product launches draw fresh attention to Bruker stock\nBruker (BRKR) gained 4% after unveiling the iNTApharma system, an expanded Fourier 80 Automation Suite, and the TITAN handheld analyzer at the Analytica 2026 conference, spotlighting its current product pipeline.\nSee our latest analysis for Bruker.\nDespite the conference bounce, Bruker’s 7 day share price return of 5.2% sits against a 30 day share price decline of 9.5% and a 1 year total shareholder return decline of 17.3%,...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","BK4121":"生命科学工具和服务","BRKR":"布鲁克"},"translate_title":"在Analytica 2026上推出新科学仪器后评估布鲁克(BRKR)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":1.5},"content_text":"AdvertisementConference product launches draw fresh attention to Bruker stock Bruker (BRKR) gained 4% after unveiling the iNTApharma system, an expanded Fourier 80 Automation Suite, and the TITAN handheld analyzer at the Analytica 2026 conference, spotlighting its current product pipeline. See our latest analysis for Bruker. Despite the conference bounce, Bruker’s 7 day share price return of 5.2% sits against a 30 day share price decline of 9.5% and a 1 year total shareholder return decline of 17.3%, pointing to short term momentum after a challenging few years. If this kind of product driven story appeals to you, it may be worth broadening your watchlist with 36 healthcare AI stocks. With the shares down over the past year but trading at a discount to both analyst targets and some intrinsic estimates, is Bruker quietly offering value here, or is the market already pricing in its next phase of growth? Most Popular Narrative: 26.1% Undervalued Bruker’s most followed narrative pegs fair value at about $48.43 per share versus the recent $35.80 close, framing the stock as materially discounted before even factoring in its product news flow.  The company's pipeline of recent innovations (e.g., next-generation tims mass spectrometry, spatial biology, automated diagnostics) positions it to benefit from sustained investment in personalized medicine, genomics, and high-throughput scientific R&D, supporting both future revenue expansion and favorable product mix improvements.  Read the complete narrative. Want to see what sits behind that gap between price and fair value? The narrative focuses on earnings power, margin lift and a very specific profit multiple. The full set of assumptions is where the story becomes more detailed. Result: Fair Value of $48.43 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, your thesis has to account for weak recent book to bill trends and helium cost pressure, which could keep margins and funding-sensitive demand under strain. Find out about the key risks to this Bruker narrative. Next Steps Given the mixed signals around Bruker, it makes sense to move quickly, review the full picture for yourself, and weigh both sides of the story with 3 key rewards and 1 important warning sign. Want more investment ideas on your radar? If Bruker has caught your attention, do not stop here. Use Simply Wall Street’s screeners to quickly surface fresh ideas that match your risk and return preferences.  Target potential mispricings by scanning for companies that combine quality with attractive entry points through the 55 high quality undervalued stocks. Strengthen your capital base by focusing on companies with healthy finances using the solid balance sheet and fundamentals stocks screener (39 results). Prioritize resilience and sleep better at night by filtering for steadier names with the 74 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Bruker might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}